Monthly Archives: October 2019
NAD+ Therapy for Alzheimer’s Disease
The incidence of Alzheimer’s disease is rapidly spreading across the globe, affecting tens of millions of people. Scientists project that the number of people afflicted with Alzheimer’s will continue to rise over the next two decades. Alzheimer’s disease is a…
NAD+ IV Therapy Gives New Hope to Sufferers of Parkinson’s Disease
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder for which there is no known cure. Once considered to be a disease of advanced old age, today the condition is affecting much younger patients, often in their late middle age. Parkinson’s…
Treatment with NAD+ for Fibromyalgia and Chronic Fatigue
Fibromyalgia (FM), also referred to as Chronic Fatigue Syndrome (CFS), is a complex and debilitating condition for which there is no known cure. FM affects between 2-4 percent of the population, and is most commonly seen in women. The specific…